Pharma Test Instruments India Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 23-12-2024
- Paid Up Capital ₹ 4.99 M
as on 23-12-2024
- Company Age 13 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -4.13%
(FY 2020)
- Profit -68.39%
(FY 2020)
- Ebitda 37.60%
(FY 2020)
- Net Worth 3.01%
(FY 2020)
- Total Assets 11.00%
(FY 2020)
About Pharma Test Instruments India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.99 M, as per Ministry of Corporate Affairs (MCA) records.
Bjoern Faehler, Chandrakanth Neelam, and Shiva Neelam serve as directors at the Company.
- CIN/LLPIN
U29219TG2011FTC124916
- Company No.
124916
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
28 Mar 2011
- Date of AGM
28 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Pharma Test Instruments India?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Bjoern Faehler  | Director | 03-Oct-2011 | Current |
Chandrakanth Neelam  | Director | 05-Nov-2014 | Current |
| Shiva Neelam | Director | 05-Nov-2014 | Current |
Financial Performance of Pharma Test Instruments India.
Pharma Test Instruments India Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 4.13% decrease. The company also saw a substantial fall in profitability, with a 68.39% decrease in profit. The company's net worth moved up by a moderate rise of 3.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Pharma Test Instruments India?
In 2019, Pharma Test Instruments India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Pharma Test Instruments India?
Unlock and access historical data on people associated with Pharma Test Instruments India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Pharma Test Instruments India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Pharma Test Instruments India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
